SecBot SecBot
EFFECT ·Filed Apr 13, 2026

ORKA

Oruka Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed7mo ago SEC9999999995-26-001154
IPO/offering going effective
Actionable Insight • Neutral

Monitor for future prospectus supplements that would signal an actual offering; absence of immediate pricing or sale details means no direct financial impact yet.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$61.38
T+0 close · Apr 13, 2026 · via day close
Latest settled
+37.50%
T+60 · $84.40
Vs SPY
+28.58%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 13 $61.38entry
  2. T+1 · 7mo ago +9.25%α +8.04% · $67.06
  3. T+5 · 7mo ago +12.20%α +8.91% · $68.87
  4. T+20 · 6mo ago +7.01%α −0.72% · $65.68
  5. T+60 · 4mo ago +37.50%α +28.58% · $84.40
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Oruka Therapeutics' $1 billion shelf registration (S-3) has become effective, allowing the company to sell common stock, preferred stock, depositary shares, or warrants from time to time. This creates a potential for future dilution, though no immediate offering has been announced.

Key Facts

  • S-3 shelf registration effective as of April 10, 2026
  • Registration allows for up to $1 billion in securities to be offered
  • Securities may include common stock, preferred stock, depositary shares, or warrants
  • Offerings can occur at any time over the next three years, with terms disclosed in future prospectus supplements

Financial Impact

Up to $1 billion in potential future dilution

dilutionequity

Risk Factors

  • Potential share dilution if and when offerings are executed
  • Market perception of equity overhang could pressure stock price

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001154
Document: 9999999995-26-001154-index.html9999999995-26-001154
Document: 9999999995-26-001154.txt9999999995-26-001154

Track record

40 reports on ORKA

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +80.05% at T+60 after the Jun 1, 2026 report. 11 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $102.46 Now $99.24 −3.14% settles Dec 15
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry price pending
  3. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $106.15 Now $99.24 −6.51% settles Dec 15
  4. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $104.89 Now $99.24 −5.39% settles Dec 15
  5. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  6. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  7. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $109.50 Now $99.24 −9.37% settles Dec 9
  8. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  9. Nov 2, 202614d ago 144 Neutral 3/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  10. Oct 26, 202621d ago 8-K Bullish 6/10 Entry $90.33 Now $99.24 +9.86% settles Nov 23
Showing 10 of 40

US Market Status

Market Closed · Opens Wed (10h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 13, 2026